Gustave Roussy Transfert

Gustave Roussy Transfert is a company in Villejuif, France that has taken part in 6 EU-funded projects since 2017.

EU funding receivedNot recorded
EU projects6
As coordinator0
Running now4
First EU project2017
Latest project2026
CountryFrance
EU registration (PIC)912980588
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Gustave Roussy Transfert's own share of each project, not the project's full budget.

  • Horizon Europe€0 · 4 projects
  • Horizon 2020€0 · 2 projects

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • COMPASSAssociated partner

    Cardio-Oncology Multidisciplinary Patient ASsistance Solution

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

  • OASISAssociated partner

    OPTIMAL METHODS TO CHARACTERIZE ADC RESISTANCE IN SOLID TUMORS AND IDENTIFY CLINICALLY USEFUL BIOMARKERS

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • CARE1Associated partner

    First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • PREVALUNG EUAssociated partner

    Biomarkers affecting the transition from cardiovascular disease to lung cancer: towards stratified interception.

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

  • ONCOBIOMEAssociated partner

    Gut OncoMicrobiome Signatures (GOMS) associated with cancer incidence, prognosis and prediction of treatment response.

    Horizon 2020 · 2019–2025 · Project on CORDIS ↗

  • ITCC-P4Associated partner

    ITCC Pediatric Preclinical POC Platform – Sofia ref.: 116064

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • cardiovascular diseases
  • ecosystems
  • homeostasis
  • internet of things
  • lung cancer
  • melanoma
  • microbiology
  • mortality
  • nutrition
  • oncology
  • pathology
  • pharmacology and pharmacy
  • proteomics
  • radiology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime